Major players in the drug screening market are LabCorp, Quest Diagnostics, Alere, OraSure, Alfa Scientific Designs, Thermo Fisher Scientific, Drägerwerk, LifeLoc, Omega Laboratories, Premier Biotech, Intoximeters, Sciteck Inc, Synens SAS, AccuSource Inc, and Creative Diagnostics.
New York, July 29, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Drug Screening Global Market Report 2022" - https://www.reportlinker.com/p06310844/?utm_source=GNW
The global drug screening market is expected to grow from $5.80 billion in 2021 to $6.58 billion in 2022 at a compound annual growth rate (CAGR) of 13.53%. The drug screening market is expected to grow to $10.66 billion in 2026 at a compound annual growth rate (CAGR) of 12.81%.
The drug screening market consists of sales of drug screening solutions and related services by entities (organizations, sole traders, and partnerships) that refer to an approach used for drug testing, identified and optimized for clinical trials used in the analysis of blood, urine, hair, or saliva to detect the presence of chemicals and pollutants and other illicit substance left in the body as a result of drug usage.The screening methods range from tests with less performance such as microscopic observation to high-performance observation.
Drug screens come in various shapes and sizes and are used for multiple applications.
The main types of drug screening products include rapid testing devices, consumables, and others.Rapid testing devices refer to easy-to-use drug screening devices that provide results quicker than the standard traditional laboratory test.
The different samples used in drug screening includes oral fluid sample, hair sample, urine sample, breath sample, and others. They are used in drug testing laboratories, workplaces, criminal justice and law enforcement, hospitals, drug treatment centres, individual users, pain management centers, schools & colleges.
North America was the largest region in the drug screening market in 2021.Asia-Pacific is expected to be the fastest-growing region in the forecast period.
The regions covered in the drug screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The drug screening market research report is one of a series of new reports that provides drug screening market statistics, including drug screening industry global market size, regional shares, competitors with a drug screening market share, detailed drug screening market segments, market trends and opportunities, and any further data you may need to thrive in the drug screening industry. This drug screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Growing drug and alcohol consumption is driving the growth of the drug screening market.Drug addiction is a disease that affects a person’s brain and behavior, resulting in the inability to control the use of a legal or illegal drug or medication.
Substances such as alcohol, marijuana, and nicotine also are considered drugs.As the drug and alcohol addiction increases, the chances of disease are higher which triggers the need for drug screening.
For instance, in June 2019 & 2020, according to a report published by the United Nations Office on Drugs and Crime (UNODC), 35 million people globally suffer from drug use disorders and require treatment services.The severity and complexity of the world drug situation are increasing, revealing that the number of people who use drugs is now 30% higher than in 2009.
The pandemic effects also ramp up drug risks, as cannabis intake by youth had increased by as much as four times in parts of the world. Therefore, growing drug and alcohol consumption is driving the growth of the drug screening market.
The development of innovative products is a key trend gaining popularity in the drug screening market.Major companies operating in the drug screening market are focusing on providing innovative products to meet fast-growing industry demand and strengthen their market position.
Additionally, due to COVID, there was a sudden change in the drug screening approach, which changed the screening methodologies and pushed the innovation and new product development by companies.Companies are striving to develop new products such as a new drug test that is more effective and can be widely used by laboratories.
For instance, in April 2019, Thermo Fisher Scientific, a US-based laboratory supply and biotechnology company introduced a new drug of abuse test with supporting calibrators and controls.Named CEDIA Mitragynine (Kratom) Assay, it can be performed on widely used clinical chemistry analyzers, allowing a wide range of laboratories to test for the presence of Kratom.
This test is only for use in criminal justice and forensics.
In January 2020, StemBioSys, Inc., a Texas-based company involved in the development, manufacturing and distribution of life science tools acquired a majority stake in CarTox, Inc. for an undisclosed amount. This acquisition is expected to boost the company’s product portfolio in the drug screening and drug toxicology sector and contribute to its strategy to expand its business presence across the globe. CarTox, Inc. is a Michigan-based developer and manufacturer of drug screening and drug toxicology solutions.
The countries covered in the drug screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.
Read the full report: https://www.reportlinker.com/p06310844/?utm_source=GNW
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001